NEURALY Trademark

Trademark Overview

On Tuesday, November 23, 2021, a trademark application was filed for NEURALY with the United States Patent and Trademark Office. The USPTO has given the NEURALY trademark a serial number of 97139436. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, November 27, 2024. This trademark is owned by Neuraly, Inc.. The NEURALY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of neurodegenerative diseases, Alzheimer's Disease, and Parkinson's Disease
neuraly

General Information

Serial Number97139436
Word MarkNEURALY
Filing DateTuesday, November 23, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, November 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2022

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of neurodegenerative diseases, Alzheimer's Disease, and Parkinson's Disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeuraly, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNeuraly, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Friday, November 26, 2021NEW APPLICATION ENTERED
Monday, November 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 3, 2022ASSIGNED TO EXAMINER
Wednesday, September 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 1, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 1, 2023SOU EXTENSION 1 FILED
Thursday, June 1, 2023SOU EXTENSION 1 GRANTED
Saturday, June 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 3, 2024SOU EXTENSION 3 GRANTED
Friday, November 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 10, 2023SOU EXTENSION 2 FILED
Friday, November 10, 2023SOU EXTENSION 2 GRANTED
Tuesday, November 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024SOU EXTENSION 3 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 27, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 27, 2024SOU EXTENSION 4 FILED
Thursday, November 28, 2024SOU EXTENSION 4 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

neuraly disease parkinson alzheimer diseases treatment neurodegenerative pharmaceuticals